These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32663580)

  • 1. A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatment.
    Khadka P; Hill PC; Zhang B; Katare R; Dummer J; Das SC
    Int J Pharm; 2020 Sep; 587():119602. PubMed ID: 32663580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
    Momin MAM; Tucker IG; Das SC
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.
    Mangal S; Huang J; Shetty N; Park H; Lin YW; Yu HH; Zemlyanov D; Velkov T; Li J; Zhou QT
    Int J Pharm; 2019 Apr; 561():102-113. PubMed ID: 30797863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Solvato-) polymorphism of formulations of rifampicin for pulmonary drug delivery prepared using a crystallization/spray drying process.
    Berkenfeld K; McConville JT; Lamprecht A
    Int J Pharm; 2020 Nov; 590():119932. PubMed ID: 33011253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new respirable form of rifampicin.
    Son YJ; McConville JT
    Eur J Pharm Biopharm; 2011 Aug; 78(3):366-76. PubMed ID: 21324356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of sustained release rifampicin microparticles for inhalation.
    Son YJ; McConville JT
    J Pharm Pharmacol; 2012 Sep; 64(9):1291-302. PubMed ID: 22881441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats.
    Khadka P; Sinha S; Tucker IG; Dummer J; Hill PC; Katare R; Das SC
    Eur J Pharm Biopharm; 2021 May; 162():1-11. PubMed ID: 33639255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
    Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid state of inhalable high dose powders.
    Adhikari BR; Gordon KC; Das SC
    Adv Drug Deliv Rev; 2022 Oct; 189():114468. PubMed ID: 35917868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable formulations of rifampicin by spray drying of supersaturated aqueous solutions.
    Berkenfeld K; McConville JT; Lamprecht A
    Eur J Pharm Biopharm; 2020 Aug; 153():14-22. PubMed ID: 32446961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Das SC
    Int J Pharm; 2018 May; 543(1-2):318-327. PubMed ID: 29626509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis.
    Aekwattanaphol N; Das SC; Khadka P; Nakpheng T; Ali Khumaini Mudhar Bintang M; Srichana T
    Int J Pharm; 2024 Oct; 664():124608. PubMed ID: 39163929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.
    Momin MAM; Sinha S; Tucker IG; Doyle C; Das SC
    Int J Pharm; 2017 Aug; 528(1-2):107-117. PubMed ID: 28583333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.
    Zhou QT; Gengenbach T; Denman JA; Yu HH; Li J; Chan HK
    AAPS J; 2014 Jan; 16(1):37-47. PubMed ID: 24129586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
    Pathak V; Park H; Zemlyanov D; Bhujbal SV; Ahmed MU; Azad MAK; Li J; Zhou QT
    Pharm Res; 2022 Nov; 39(11):2781-2799. PubMed ID: 35915320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders.
    Zhang Q; Li Y; Li L; Cheng Y; Yu F; Li R; Hou S
    AAPS PharmSciTech; 2023 Mar; 24(3):78. PubMed ID: 36918500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray dried inhalable ivacaftor co-amorphous microparticle formulations with leucine achieved enhanced in vitro dissolution and superior aerosol performance.
    Guan J; Yuan H; Yu S; Mao S; Tony Zhou Q
    Int J Pharm; 2022 Jun; 622():121859. PubMed ID: 35643348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
    Wang J; Kutter JP; Mu H; Moodley A; Yang M
    Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.